Report Categories
View AllRecent Articles
View All
Is Ingram INGM stock showing recovery signs Ingram posts 65 percent EPS beat on strong B2B tech demand
How will Century Therapeutics IPSC earnings compare to expectations Q4 2025 Better Than Expected
Lam Research Corporation LRCX Emerging As A HighConviction AI Semiconductor Play In Billionaire Philippe Laffonts 2026 Portfolio
How Great Elm GECCO manages its cash position Great Elm Posts 115 EPS Miss Versus Consensus Estimates
KeyBanc Maintains Overweight on Microsoft as Azure Copilot Momentum Builds
Retail Traders Outperform Wall Street in Prediction Markets Emerging Analysis Suggests
Beyond Inc Acquires Buy Buy Baby Brand Rights Reunites with Bed Bath Beyond
JPMorgans Summer Reading List for Wealthy Clients Highlights AI Leadership and Lemons
CNBC Investing Clubs Portfolio Rides Market Rally Top and Bottom Performers in SixWeek Record Run
US Government Accuses First Brands of Tariff Underpayment Legal Proceedings Possible
CVV Q1 2026 Earnings Narrowing Losses as Operational Efficiencies Begin to Emerge
INSE Q1 2026 Earnings NarrowerThanExpected Loss Boosts Sentiment Despite Revenue Uncertainty
ProFrac ACDC Q4 2025 Earnings EPS Miss Deepens as Cost Pressures Offset Operational Gains
Gloo Holdings Inc GLOO Q4 2025 Earnings Net Loss of 078 per Share Stock Declines 26
ATXG Q1 2025 Earnings Narrowing a Quarterly Loss Amid Strategic Repositioning
Welltower Q1 2026 Earnings Stellar EPS Beat Bolsters Investor Confidence
Dare Bioscience DARE Edges Higher Amid Steady Support Levels
Cytokinetics Slides Modestly as Biotech Sector Struggles CYTK Hovers Near Support
CCID Preferred Shares Edge Higher Yield Remains Key Draw Near Par
Syntec Optics OPTX Surges 693 as Optics Stock Tests Key Resistance
Bold Eagle Acquisition Corp BEAG Holds Steady at 1058 as SPAC Market Awaits Catalyst